Shikonin inhibits tumor invasion via down-regulation of NF-κB-mediated MMP-9 expression in human ACC-M cells

Oral Diseases

Volumn 17, Issue 4, 2011, Pages 362-369

  Min, R ^a   Zun, Z ^b   Min, Y ^a   Wenhu, D ^c   Wenjun, Y ^a   Chenping, Z ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Adenoid cystic carcinoma; Matrix metallopeptidase 9; Nuclear factor B; Shikonin; Tumor invasion

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; SHIKONIN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, ADENOID CYSTIC; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; I-KAPPA B PROTEINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NAPHTHOQUINONES; NEOPLASM INVASIVENESS; NF-KAPPA B; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953756477     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01758.x     Document Type: Article

References (30)

1. Beppu M, Ikebe T, Shirasuna K (2002). The inhibitory effects of immuno-suppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer. Biochim Biophys Acta 1586: 11-22.
2. Chen X, Yang L, Oppenheim JJ, Howard MZ (2002). Cellular pharmacology studies of shikonin derivatives. Phytother Res 16: 199-209.
3. Gaddipati JP, Mani H, Shefali et al (2000). Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA). Anticancer Res 20: 2547-2552.
4. Gu Z, Qiu W, He R, Zhang Z, Zhou X (1999). Selection of quantitative criteria for evaluating metastases of a highly metastatic salivary adenoid cystic carcinoma cell line to the lungs of nude mice. Chin J Dent Res 2: 16-20.
5. HemaIswarya S, Doble M (2006). Potential synergism of natural products in the treatment of cancer. Phytother Res 20: 239-249.
6. Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ (1998). Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastasis 16: 169-177.
7. Hu Y, Ivashkiv LB (2006). Costimulation of chemokine receptor signaling by matrix metalloproteinase-9 mediates enhanced migration of IFN-alpha dendritic cells. J Immunol 176: 6022-6033.
8. Huang M, Ma D, Sun K, Yu G, Guo C, Gao F (1997). Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 26: 435-439.
9. Hussain AR, Al-Jomah NA, Siraj AK et al (2007). Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res 67: 3888-3897.
10. Iimuro Y, Nishiura T, Hellerbrand C et al (1998). NF-kB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 101: 802-811.
11. Ji H, Ramsey MR, Hayes DN et al (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807-810.
12. Karin M (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
13. Kayano K, Shimada T, Shinomiya T et al (2004). Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. J Pathol 202: 403-411.
14. Kossakowska AE, Edwards DR, Prusinkiewicz C et al (1999). Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 94: 2080-2089.
15. Pahl HL (1999). Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18: 6853-6866.
16. Pikarsky E, Porat RM, Stein I et al (2004). NF-kB functions as a tumour promoter in inflammation-associated cance. Nature 431: 461-466.
17. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB (2000). Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20: 645-651.
18. Rahman A, Anwar KN, True AL, Malik AB (1999). Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol 162: 5466-5476.
19. Repesh LA (1998). A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 9: 192-208.
20. Ruan M, Tong J, Wenjun Y et al (2008). Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway. Phytother Res 22: 407-415.
21. Singh F, Gao D, Lebwohl MG, Wei H (2003). Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells. Cancer Lett 200: 115-121.
22. Spiro RH (1986). Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck 8: 177-184.
23. Stetler-Stevenson WG (2001). The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am 10: 383-392.
24. Sung MW, Kim KH, Kim JW et al (2003). Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129: 1193-1197.
25. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37: 375-536.
26. de Vicente JC, Lequerica-Fernández P, López-Arranz JS, Esteban I, Fresno MF, Astudillo A (2008). Expression of matrix metalloproteinase-9 in high-grade salivary gland carcinomas is associated with their metastatic potential. Laryngoscope 118: 247-251.
27. Wu Z, Wu L, Li L, Tashiro S, Onodera S, Ikejima T (2004). P53-mediated cell cycle arrest and apoptosis induced by Shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells. J Pharmacol Sci 94: 166-176.
28. Yeh CC, Wu LT, Lin SY, Li TM, Chung JG (2004). The inhibition of N-acetyltransferase activity and gene expression in human bladder cancer cells (T24) by shikonin. In Vivo 18: 21-31.
29. Yoon Y, Kim Y, Lim N, Jeon W, Sung HJ (1999). Shikonin, an ingredient of Lithospermum erythrorhizon induced apoptosis in HL60 human premyelocytic leukemia cell line. Planta Med 65: 532-535.
30. Zhang J, Peng B (2007). In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. BMC Cancer 1: 95.